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duration of known diabetes was 6.80 ± 6.67 years. A substantial negative impact of 
diabetes on the participants’ HRQoL was observed as assessed by the ADDQoL (mean 
± SD average weighted impact (AWI) score: −3.76 ± 2.03 from the possible range −9 to 
+3), although the level of their TS was rather high as assessed by the DTSQs (mean ± 
SD TS scale total: 28.60 ± 5.53 out of 36). The participants’ EQ-5D scores (mean ± SD 
EQ-utility score: 0.74 ± 0.20; EQ-VAS score: 65.22 ± 17.54) were only slightly lower 
than the norm values for the general population (0.80 ± 0.26 and 79.74 ± 18.23 for the 
two scores, respectively). Higher income was signiﬁ cantly associated with better health 
status while lower education and unemployment status were signiﬁ cantly associated with 
poorer HRQoL. Female gender and older age were associated with higher TS. CON-
CLUSIONS: Diabetes had major impact on the participants’ HRQoL but little impact 
on health status despite a high level of TS. Patient characteristics associated with these 
outcomes were also different. 
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OBJECTIVES: To develop a Thai version of the Audit of Diabetes-Dependent Quality 
of Life (ADDQoL-19) and to evaluate its psychometric properties among Thai patients 
with diabetes. METHODS: This study was conducted by ﬁ rstly cross-culturally adapt-
ing the original English ADDQoL-19 into Thai, followed by administering the Thai 
version together with the Thai EQ-5D and sociodemographic questionnaire to patients 
(aged >18 years) with diabetes recruited from a tertiary hospital in central Thailand 
by simple random sampling. The usefulness of a ‘not applicable’ (N/A) option and the 
necessary of weighting the impact scores, factor structure and internal consistency 
reliability of the Thai ADDQoL-19 were assessed. Data were subjected to conﬁ rma-
tory factor analysis (CFA) using structural equation modeling (SEM) and exploratory 
factor analysis (EFA) using principal component analysis (PCA). The known-groups 
validity of the Thai ADDQoL was assessed by four a priori hypotheses. RESULTS: 
The Thai ADDQoL-19 was shown to be conceptually equivalent to its original version 
and culturally relevant to Thai patients with diabetes. Its psychometric properties were 
evaluated among 201 diabetic patients (71.1% females; 81.6% primary educated; 
mean age 54.25 [SD = 9.8] years). Its unique characteristics, i.e., weighting and indi-
vidualization were proved to be necessary for a more accurate assessment of quality 
of life. The Thai ADDQoL-19 also demonstrated a good internal consistency reli-
ability, with the Cronbach’s alpha of 0.90. However, the ﬁ t indices derived from a 
CFA failed to achieve a good ﬁ t (i.e., >0.90). EFA with forced-one factor solution 
showed factor loadings above 0.40 for all items, except for sexual relationship. The 
known-groups validity was also not clear as only two hypotheses were fully fulﬁ lled. 
CONCLUSIONS: The Thai ADDQoL-19 has shown to be culturally appropriate and 
highly reliable but requires further investigations to provide more evidence on its 
factor structure and known-groups validity before its utilization in routine clinical 
settings. 
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OBJECTIVES: The two most commonly used insulin delivery devices, pens and 
syringes, have comparable safety proﬁ les and efﬁ cacy under similar use conditions. 
Therefore, the decision regarding the preferred device must be based on other consid-
erations such as treatment satisfaction, treatment adherence, health-related quality of 
life (HRQoL), health-care expenditure and utilization. METHODS: A literature search 
was conducted of published articles in peer reviewed journals listed in the US National 
Library of Medicine’s PubMed (1948–present), DIALOG including PsychInfo (1887–
present), EMCARE (nursing lit., 1995–present), BIOSIS (1993–present), EMBASE 
(Excerpta Medica, 1974–present), SciSearch (1990–present) and MEDLINE. Relevant 
manuscripts were classiﬁ ed into subcategories based on the major focus of the article 
reviewed and then subcategories were collapsed into major categories: treatment 
satisfaction, treatment adherence, HRQoL, and health-care expenditure and utiliza-
tion. RESULTS: A total of 135 publications were reviewed for inclusion of which 73 
manuscripts and nine conference abstracts/poster were deemed relevant and reviewed 
in depth. Seventeen reported ﬁ ndings from clinical trials and 13 were review articles. 
There is substantial evidence demonstrating the superior beneﬁ ts of pens over syringes. 
Treatment satisfaction and patient preference for pens over syringes was widely 
reported and patients reported that pens provided them with increased conﬁ dence in 
dose, ability to self-inject, superior convenience and overall ease of use. Pen users 
reported better treatment adherence and fewer missed insulin doses which may 
account for the reported better HbA1c control than with syringe. Health-care expen-
diture and utilization were higher in the short term for pens; however, these expendi-
tures were minor in comparison with long-term savings that result from improved 
decreases in hospitalizations, incidence of side effects, physician visits and emergency 
department visits. CONCLUSIONS: Long- and short-term diabetes management 
should beneﬁ t from the choice of pen as the insulin delivery method based on PRO 
outcomes and long term cost effectiveness. 
PDB18
THE PREVALENCE AND IMPACT OF BEING AT-RISK FOR DIABETES 
ACROSS US, JAPAN, AND EUROPE
DiBonaventura MD1, Iwamoto K2, Nakahara N3, Fukuda T4, Nagae T5, Wagner JS1, 
Stankus A6
1Kantar Health, New York, NY, USA; 2Eli Lilly Japan K.K., Chuo-ku, Kobe, Japan; 3Eli Lilly Japan 
K.K., Kobe, Japan; 4Tokyo University, Tokyo, Japan; 5York Pharma KK, Tokyo, Japan; 6Kantar 
Health, Princeton, NJ, USA
OBJECTIVES: As diabetes rates rise, it is important to understand the proﬁ le of those 
who are at-risk for developing diabetes but have not yet been diagnosed. The aim of 
this study was to assess the burden for these high-risk patients. METHODS: The 
current study used US 2009, EU 2008, and Japan 2008 datasets from the National 
Health and Wellness Survey (NHWS). Implementing a previously-developed algo-
rithm, all patients not diagnosed with diabetes were classiﬁ ed as having or not having 
a high risk for developing diabetes. High-risk patients were compared with controls 
on health-related quality of life (physical component summary (PCS) scores of the 
SF-12v2) and the number of emergency room (ER) visits controlling for demographics 
(country, age, gender, ethnicity, income, education) and patient characteristics (BMI 
and Charlson comorbidity index). RESULTS: Of patients not diagnosed with diabetes, 
16.64% (n = 10778) in the United States, 14.33% (n = 7481) in the EU, and 4.05% 
(n = 750) in Japan were classiﬁ ed as being at high risk for diabetes. After controlling 
for demographics and patient characteristics, those at high risk reported signiﬁ cantly 
lower levels of PCS across all three countries (Adjusted Mean [Madj] = 46.2 vs. 49.6, 
P < 0.0001) than controls. The effect was stronger in the EU (M-adj = 45.5 vs. M-adj 
= 49.2) and weaker in Japan (M-adj = 47.9 vs. M-adj = 49.8) relative to the United 
States (M-adj = 46.6 vs. M-adj = 49.7). Those at high risk reported signiﬁ cantly fewer 
ER visits (Madj = 0.12 vs. M-adj = 0.16, P < 0.0001) than controls, however, this effect 
was reversed in Japan in that those at high risk reported signiﬁ cantly more ER visits 
than controls (M-adj = 0.21 vs. M-adj = 0.12, P < 0.0001). CONCLUSIONS: A sub-
stantial number of patients are at a high risk for developing diabetes, particularly in 
the United States and EU. The physical quality of life was signiﬁ cantly lower, particu-
larly in the EU and the United States, and in Japan this group reported signiﬁ cantly 
more ER visits than controls. 
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OBJECTIVES: Diabetes Mellitus (DM) can reduce patients’ physical well-being and 
compromise other aspects of quality of life. This study aims to investigate the health-
related quality of life (HRQoL) of DM patients under primary care, and the associa-
tions of HRQoL with demographic factors and HbA1c control. Previous studies that 
examined these associations yielded mixed results and none was done in Singapore. 
METHODS: A cross-sectional, interviewer-administered survey was conducted in 
either English or Chinese, depending on the patient’s language of preference, between 
September and December 2009 in a convenience sample of 301 DM patients who 
were ≥21 years old, on hypoglycemic agent(s), with at least a year of DM history, and 
followed up at two outpatient clinics. Survey instrument included demographic ques-
tions and one generic and one DM-speciﬁ c HRQoL measures, i.e., EQ-5D and the 
Audit of Diabetes-Dependent Quality of Life (ADDQoL), respectively. Patients’ most 
recent HbA1c values were extracted from medical records in the clinics. RESULTS: 
The average EQ-5D score was 0.89 ± 0.16 and ADDQoL average weighted impact 
(AWI) score was −2.5 ± 2.0. Pain was the most common complaint among the ﬁ ve 
EQ-5D domains (by 28% of the respondents). Lack of freedom to eat was the 
ADDQoL domain with the greatest negative impact (AWI = −3.8, on a scale of −9 to 
3). A signiﬁ cant association was observed between ADDQoL AWI and both duration 
of diabetes (P = 0.005) and use of insulin (P = 0.014). A negative correlation was 
found between HRQoL and HbA1c values in both HRQoL measures (both r = −0.2, 
P < 0.01). CONCLUSIONS: DM patients in primary care settings frequently reported 
problems with pain and restrictions in diet. Poorer HRQoL was found to be associated 
with higher HbA1c, which indicates poorer glycemic control. The chronicity of DM 
and use of insulin may have negative impact on patients’ HRQoL. 
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OBJECTIVES: To examine the association between patterns of cardiovascular medica-
tion use and health-related quality of life (HRQoL) in elderly Australian women with 
diabetes. METHODS: A cross-sectional study was conducted using older cohort com-
pleting Survey 4 in the Australian Longitudinal Study on Women’s Health (ALSWH) 
who self-reported to have been diagnosed with diabetes and/or use medications indica-
tive of diabetes. Use of cardiovascular medications was identiﬁ ed from self-reported 
medications belonging to the Anatomical Therapeutic Chemical (ATC) code B01AC, 
C03, C07, C08, C09, C02 and C10. Usage patterns were classiﬁ ed as no use, using any 
hypertensives, lipid lowering agents or antiplatelet drugs, using any two classes, and 
using all the three classes. The SF-36 was used to measure HRQoL, focusing on the 
